Pronova Biopharma Says German Court Rules in Favour on Post-MI
Pronova BioPharma (PRON) ASA said the German Federal Patent Court ruled in Pronova and Pfizer (PFE) Italia’s favor in the patent litigation involving German Patent No. EP 1 152 755 covering Post-MI use in Germany.
To contact the editor responsible for this story: Meera Bhatia at firstname.lastname@example.org
Bloomberg moderates all comments. Comments that are abusive or off-topic will not be posted to the site. Excessively long comments may be moderated as well. Bloomberg cannot facilitate requests to remove comments or explain individual moderation decisions.